prolaio eVO2peak Module (Version 1.0)

FDA 510(k) K252204 · Prolaio, Inc.

Substantially Equivalent

510(k) numberK252204

Submission

Device name
prolaio eVO2peak Module (Version 1.0)
Applicant
Prolaio, Inc.
Chicago, IL, US
Received
July 14, 2025
Decision date
December 16, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PPW – Adjunctive Cardiovascular Status Indicator
Device class
Class II (moderate risk)
Regulation
21 CFR 870.2200
Specialty
Cardiovascular

The adjunctive cardiovascular status indicator is a prescription device based on sensor technology for the measurement of a physical parameter(s). This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Other 510(k)s with product code PPW

510(k)DeviceApplicantDecision
K254066Etiometry PlatformPPW · Special Etiometry, Inc.04/03/2026SE
K241479Etiometry Platform (DAV 5.4 RAE 9.2)PPW · Traditional Etiometry, Inc.02/12/2025SE
K223578T3 Platform softwarePPW · Traditional Etiometry, Inc.07/07/2023SE
K213230T3 Platform SoftwarePPW · Traditional Etiometry, Inc.06/22/2022SE
K213255CipherOx CRI TabletPPW · Traditional Flashback Technologies, Inc.06/17/2022SE
K173929CipherOx CRI M1PPW · Traditional Flashback Technologies, Inc.07/24/2018SE

Questions and answers

When was prolaio eVO2peak Module (Version 1.0) cleared by the FDA?

prolaio eVO2peak Module (Version 1.0) (K252204) received a 510(k) decision of Substantially Equivalent on December 16, 2025, 155 days after the submission was received.

What is the product code of K252204?

The FDA product code is PPW – Adjunctive Cardiovascular Status Indicator, a Class II (moderate risk) device regulated under 21 CFR 870.2200.